Heparins, warfarin and direct oral anticoagulants: how they work, monitoring and reversal
- Treatment and support
Anticoagulants prevent and treat clots but cause much serious drug-related bleeding. How each one works tells you how to check it and undo it.
What it is
Anticoagulants block the clotting cascade at different points. Heparins work through antithrombin: unfractionated heparin blocks thrombin and factor Xa, low-molecular-weight heparins mainly Xa, and fondaparinux only Xa. Warfarin blocks the recycling of vitamin K, so the liver releases unfinished factors II, VII, IX and X. Direct oral anticoagulants (DOACs) bind their target directly: dabigatran blocks thrombin; rivaroxaban, apixaban and edoxaban block factor Xa. Parenteral direct thrombin inhibitors (argatroban, bivalirudin) are used mainly in HIT.
What to know
- Unfractionated heparin: intravenous, short-acting, monitored by aPTT or anti-Xa, fully reversed by protamine; useful when quick on and off matters and in severe kidney failure.
- Low-molecular-weight heparins (enoxaparin, dalteparin): subcutaneous, cleared by the kidney, no routine monitoring (anti-Xa in kidney failure, pregnancy or extreme weight); protamine reverses them only partly; the anticoagulant of choice in pregnancy.
- Warfarin: slow onset and offset, monitored by INR; many food and drug interactions; harms the fetus; reversed by vitamin K plus prothrombin complex concentrate. Still preferred with mechanical heart valves and high-risk antiphospholipid syndrome.
- Dabigatran: oral thrombin inhibitor, largely cleared by the kidney, removable by dialysis; specific reversal with idarucizumab.
- Rivaroxaban, apixaban, edoxaban: oral Xa inhibitors; andexanet alfa reverses them where available, otherwise prothrombin complex concentrate is used.
- DOACs need no routine monitoring, but are avoided with mechanical valves, in pregnancy and breastfeeding, in high-risk antiphospholipid syndrome and in severe kidney failure.
How it is done (and why)
- Start warfarin with a heparin overlap in acute clots: protein C falls first, so warfarin alone is briefly procoagulant (warfarin skin necrosis).
- Choose by the patient: kidneys, liver, pregnancy, mechanical valve, APS, interacting drugs, cost and access to monitoring.
- Check kidney function before a DOAC or low-molecular-weight heparin and periodically after, since both depend on it.
- Check interactions: strong inhibitors or inducers of liver enzymes and drug pumps change DOAC levels; many antibiotics and amiodarone change the INR.
- Before surgery, plan stop and restart by drug, kidneys and procedure bleeding risk; heparin bridging is mainly for warfarin with high clot risk.
Anticoagulants side by side
| Drug | Target | Test that sees it | Reversal | Key limit |
|---|---|---|---|---|
| Unfractionated heparin | Thrombin and Xa, via antithrombin | aPTT or anti-Xa | Protamine (complete) | HIT risk highest; needs an infusion |
| Low-molecular-weight heparin | Mainly Xa, via antithrombin | Anti-Xa | Protamine (partial) | Builds up in kidney failure |
| Fondaparinux | Xa, via antithrombin | Anti-Xa (drug-calibrated) | No specific agent | Long-acting; kidney |
| Warfarin | Vitamin K recycling (II, VII, IX, X, C, S) | INR | Vitamin K plus prothrombin complex concentrate | Interactions, slow, teratogenic |
| Dabigatran | Thrombin, directly | Thrombin time (dilute for level) | Idarucizumab; dialysis | Kidney clearance |
| Rivaroxaban, apixaban, edoxaban | Xa, directly | Calibrated anti-Xa | Andexanet alfa or prothrombin complex concentrate | Not with mechanical valves or in pregnancy |
Risks and precautions
- Bleeding risk rises with age, kidney or liver disease, previous bleeding, alcohol, and use of antiplatelets or NSAIDs alongside.
- HIT can follow any heparin, including line flushes; a falling platelet count 5–10 days in needs checking.
- Patients on warfarin should keep vitamin K intake steady rather than avoid green vegetables.
- Missed DOAC doses lose protection within a day because of the short half-life; adherence matters more than with warfarin.
Monitoring and next step
- Baseline before any anticoagulant: count, PT, aPTT, creatinine and liver tests.
- Unfractionated heparin: aPTT or anti-Xa at set intervals; platelet count for HIT.
- Warfarin: INR often at the start, then at longer intervals once stable, and after any new drug.
- DOACs and low-molecular-weight heparins: kidney function at least yearly, more often in the elderly or with kidney disease.
- Urgent surgery or bleeding on a DOAC: drug-specific levels if the laboratory offers them.
Common traps
- Expecting the INR or aPTT to measure DOAC effect: they are unreliable, and a normal result does not exclude a relevant level.
- Starting warfarin alone for an acute clot: the early fall in protein C makes it procoagulant for the first days.
- Using a DOAC with a mechanical heart valve or in triple-positive antiphospholipid syndrome: warfarin works better there.
- Counting on protamine to fully reverse low-molecular-weight heparin: it reverses it only partly, and fondaparinux not at all.
Test yourself
Think of the answer, then tap the question to see it.
Why is warfarin started together with heparin in acute DVT rather than alone?
Protein C has a short half-life and falls before factors II, IX and X, so warfarin is briefly procoagulant; heparin covers this gap until the INR is in range.
Why does protamine reverse unfractionated heparin fully but low-molecular-weight heparin only partly?
Protamine binds long heparin chains; low-molecular-weight heparin has many short chains, whose anti-Xa activity protamine neutralises poorly.
Which anticoagulant is preferred in pregnancy, and why are warfarin and DOACs avoided?
Low-molecular-weight heparin, which does not cross the placenta; warfarin harms the fetus and DOACs cross the placenta with too little safety data.
A patient on apixaban has a normal PT and aPTT before emergency surgery. Can apixaban be ignored?
No: routine tests are insensitive to apixaban; a calibrated anti-Xa level or the time since the last dose and kidney function decide.
Elsewhere in DurgiPedia
- The coagulation cascade
- Fibrinolysis and natural anticoagulants
- Vitamin K epoxide reductase (VKORC1)
- Warfarin embryopathy
- Patients on anticoagulants: bleeding watch, monitoring tests, interactions and teaching
- Anticoagulants, antiplatelets and neuraxial blocks
- Anticoagulants and antiplatelets before dental extraction
Connections
Educational content; it does not replace assessment by a doctor or your institution's protocols. It contains no doses.
Sources: Heparin Injection: MedlinePlus Drug Information (MedlinePlus (U.S. National Library of Medicine), 2025); Warfarin: MedlinePlus Drug Information (MedlinePlus, US National Library of Medicine, 2026); Apixaban: MedlinePlus Drug Information (MedlinePlus (U.S. National Library of Medicine), 2025); Perioperative Anticoagulation Management (StatPearls (NCBI Bookshelf), 2023).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
